BeiGene
BGNE
#967
Rank
C$29.04 B
Marketcap
$265.49
Share price
0.49%
Change (1 day)
11.72%
Change (1 year)
BeiGene is a Chinese pharmaceutical company engaged in the R&D, and commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

We have found no dividend yield history for this company